Fate Therapeutics, Inc. (FATE)
NASDAQ·Healthcare·Biotechnology
$1.98
+4.21%
Mkt Cap $234.28M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (21 analysts)
$4.00
Range $4.00 – $4.00
Implied Upside
+102.0%
Consensus $4.00 vs current $1.98
NASDAQ·Healthcare·Biotechnology
$1.98
+4.21%
Mkt Cap $234.28M
Buy
2
Hold
0
Sell
0
Price Target (21 analysts)
$4.00
Range $4.00 – $4.00
+102.0%
Consensus $4.00 vs current $1.98